Our study provides further evidence of the promising role for FGFR-3 in the diagnosis and treatment of the large, nested variant of urothelial carcinoma, possibly implicating other targetable pathways compared to random unselected variants of urothelial carcinoma. Here, FGFR3 is linked to urothelial carcinoma.